[1]
|
Recent Advances in Biological Active Sulfonamide based Hybrid
Compounds Part C: Multicomponent Sulfonamide Hybrids
Current Medicinal Chemistry,
2023
DOI:10.2174/0929867330666221128142730
|
|
|
[2]
|
Recent Advances in Biological Active Sulfonamide based Hybrid
Compounds Part C: Multicomponent Sulfonamide Hybrids
Current Medicinal Chemistry,
2023
DOI:10.2174/0929867330666221128142730
|
|
|
[3]
|
Molecular Docking, Design, Synthesis, Characterization and Pharmacological Evaluation of New 2-hydrazinel Oxazole containing moiety as anti-proliferative activity
Bionatura,
2023
DOI:10.21931/RB/CSS/2023.08.04.10
|
|
|
[4]
|
Comprehensive Heterocyclic Chemistry IV
2022
DOI:10.1016/B978-0-12-409547-2.14936-4
|
|
|
[5]
|
Comprehensive Heterocyclic Chemistry IV
2022
DOI:10.1016/B978-0-12-409547-2.14936-4
|
|
|
[6]
|
An Overview on Synthetic 2-Aminothiazole-Based Compounds Associated with Four Biological Activities
Molecules,
2021
DOI:10.3390/molecules26051449
|
|
|
[7]
|
Anticancer Activity Screening of a Series of Imidazo[2,1‐c][1,2,4]triazolone and Imidazo[1,2 ‐b][1,2,4]triazolone Derivatives Synthesized Under Solvent Free Conditions
ChemistrySelect,
2020
DOI:10.1002/slct.201904624
|
|
|
[8]
|
Anticancer Activity Screening of a Series of Imidazo[2,1‐c][1,2,4]triazolone and Imidazo[1,2 ‐b][1,2,4]triazolone Derivatives Synthesized Under Solvent Free Conditions
ChemistrySelect,
2020
DOI:10.1002/slct.201904624
|
|
|
[9]
|
A Visible-Light-Mediated Protocol: One-Pot-Three-Component, Sustainable Synthesis of 1,3,4-Thiadiazines
ChemistrySelect,
2018
DOI:10.1002/slct.201801508
|
|
|
[10]
|
A Visible‐Light‐Mediated Protocol: One‐Pot‐Three‐Component, Sustainable Synthesis of 1,3,4‐Thiadiazines
ChemistrySelect,
2018
DOI:10.1002/slct.201801508
|
|
|